UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins
膜结合蛋白的紫外等离子增强手性光谱
基本信息
- 批准号:10680969
- 负责人:
- 金额:$ 41.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-23 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Summary
Circular dichroism (CD) and Raman optical activity (ROA) are chiroptical spectroscopies that provide valuable
structural information about biomolecules and pharmaceuticals under native conditions in aqueous buffer without
the need for special sample preparation or crystallization. The two methods are complementary as they probe
the circular dichroism of molecular electronic and molecular vibrational transitions, respectively. A combination
of the two methods is particularly well suited for investigating the structure of membrane binding proteins, which
remain very difficult to characterize with other biophysical characterization tools. Although in theory a combined
CD / ROA characterization has the potential for providing important structural information of membrane binding
proteins, in practice the weak sensitivities of the two spectroscopies makes it difficult to realize this potential. A
need for high sample concentrations and long acquisition times has limited a more widespread use of CD and
in particular ROA spectroscopy as tool for characterizing membrane binding proteins. This project intends to
overcome the sensitivity limitations of CD and ROA spectroscopies by developing plasmon-enhanced CD
(PECD) and surface-enhanced ROA (SEROA) spectroscopies that utilize plasmonic nanoantennas, which are
engineered nanostructures with specific electric (E) and magnetic (H) field properties as well as defined phase
properties, to enhance signal intensities. To maximize the signal enhancement, antenna substrates will be
developed with plasmon resonances in the ultraviolet (UV) so that the electromagnetic resonances can overlap
with the molecular electronic resonances of biological target molecules, facilitating strong signal intensities for
both CD and ROA. As this proposal focuses on developing PECD and SEROA as characterization tool for
membrane binding proteins, another important design component of the proposed antennas is the assembly of
a lipid membrane on the surface of the plasmonic nanoantennas to provide binding sites for membrane binding
proteins. This approach enriches the proteins of interest in electromagnetic hot spots where CD and ROA signal
enhancements are highest and allows for a spectroscopic characterization of the protein structure in its
membrane-bound form. The developed plasmon-enhanced spectroscopies will enable important new insights
into the structure and chirality of membrane-binding proteins, for instance as function of lipid compositions, and
will contribute to a greatly improved understanding of protein-membrane interactions. The specific aims of this
application are to:
Aim 1: Develop a Plasmon-Enhanced Ultraviolet CD Spectroscopy for Membrane Binding Proteins
Aim 2: Develop Plasmon Enhanced Raman Optical Activity (ROA) Spectroscopy for Membrane Binding Proteins
Aim 3: Prototype Combined Electronic CD / ROA Instrument for the Characterization of Membrane Binding
Proteins
概括
圆二色性(CD)和拉曼光学活动(ROA)是手势光谱,可提供有价值的光谱
在没有水性缓冲液中的天然条件下,有关生物分子和药品的结构信息
需要特殊样品制备或结晶的需求。这两种方法是互补的
分子电子和分子振动转变的圆形二色性。组合
这两种方法特别适合研究膜结合蛋白的结构,
使用其他生物物理表征工具来表征非常困难。虽然从理论上讲
CD / ROA表征有可能提供膜结合的重要结构信息
蛋白质在实践中,两种光谱镜的敏感性较弱,因此很难意识到这一潜力。一个
需要高样本浓度和长期获取时间的需求限制了CD的广泛使用和
特别是ROA光谱作为表征膜结合蛋白的工具。这个项目打算
通过开发等离子体增强CD来克服CD和ROA光谱的灵敏度限制
(PECD)和表面增强的ROA(Seroa)光谱镜,利用等离子纳米antennas
具有特定电气(E)和磁场特性的工程纳米结构以及定义的相位
属性,以增强信号强度。为了最大化信号增强,天线底物将是
用紫外线(UV)中的等离子共振开发,以使电磁共振可以重叠
随着生物靶标分子的分子电子共振,促进了强信号强度
CD和ROA。由于该建议着重于开发PECD和Seroa作为特征工具
膜结合蛋白,所提出天线的另一个重要设计组成部分是组装
等离激元纳米antennans表面上的脂质膜,以提供膜结合的结合位点
蛋白质。这种方法丰富了电磁热点中感兴趣的蛋白质,其中CD和ROA信号
增强功能是最高的,可以在其蛋白质结构中进行光谱表征
膜结合形式。开发的等离子增强光谱镜将使重要的新见解
进入膜结合蛋白的结构和手性,例如作为脂质组成的功能,而
将有助于对蛋白质 - 膜相互作用的大大改善。这个特定的目的
应用程序是:
AIM 1:为膜结合蛋白开发等离子体增强的紫外线CD光谱
AIM 2:开发血浆增强的拉曼光活性(ROA)光谱膜的膜结合蛋白
AIM 3:原型组合电子CD / ROA仪器,用于表征膜结合
蛋白质
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Bjoern Markus Rein...的其他基金
Interferometric Plasmon Ruler for Elucidating Structural Dynamics on the SingleMolecule Level
用于阐明单分子水平结构动力学的干涉等离子体尺
- 批准号:1070702710707027
- 财政年份:2022
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Interferometric Plasmon Ruler for Elucidating Structural Dynamics on the SingleMolecule Level
用于阐明单分子水平结构动力学的干涉等离子体尺
- 批准号:1045031010450310
- 财政年份:2022
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
照亮表皮生长因子受体中的动态受体簇
- 批准号:76329887632988
- 财政年份:2009
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor Signal Transduction Pathway Using Plasmon Coupling
使用等离子耦合照亮表皮生长因子受体信号转导途径中的动态受体聚类
- 批准号:1031078910310789
- 财政年份:2009
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor Signal Transduction Pathway Using Plasmon Coupling
使用等离子耦合照亮表皮生长因子受体信号转导途径中的动态受体聚类
- 批准号:1061072510610725
- 财政年份:2009
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
照亮表皮生长因子受体中的动态受体簇
- 批准号:85786938578693
- 财政年份:2009
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor Signal Transduction Pathway Using Plasmon Coupling
使用等离子耦合照亮表皮生长因子受体信号转导途径中的动态受体聚类
- 批准号:1037678110376781
- 财政年份:2009
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
照亮表皮生长因子受体中的动态受体簇
- 批准号:84445308444530
- 财政年份:2009
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor Signal Transduction Pathway Using Plasmon Coupling
使用等离子耦合照亮表皮生长因子受体信号转导途径中的动态受体聚类
- 批准号:1052407510524075
- 财政年份:2009
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
照亮表皮生长因子受体中的动态受体簇
- 批准号:82383698238369
- 财政年份:2009
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
相似国自然基金
α-突触核蛋白与脂肪酸结合蛋白FABP3相互作用维持自身低聚体形态的机制研究
- 批准号:82301632
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脂肪酸结合蛋白4(FABP4)调控肾小管上皮细胞铁死亡在移植肾功能延迟恢复 (DGF)中的机制研究
- 批准号:82360154
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
O-糖链芯片构建新方法及受体蛋白结合O-糖链的筛选与制备
- 批准号:32371342
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
双链RNA结合蛋白协同调控水稻株型与抗逆性的耦合机制及育种利用
- 批准号:32372125
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
低磷诱导钙调素结合蛋白RAPS1泛素化降解和调控根际酸化的分子机制
- 批准号:32370283
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Mechanistic evaluation of mast cell agonists combined with TLR, NOD and STING agonists.
肥大细胞激动剂联合 TLR、NOD 和 STING 激动剂的机制评估。
- 批准号:1065784710657847
- 财政年份:2023
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
O-polysaccharide (OPS)-IpaB Conjugate Vaccine to Prevent Shigellosis
O-多糖 (OPS)-IpaB 结合疫苗预防志贺氏菌病
- 批准号:1070481510704815
- 财政年份:2023
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Caries resistance mechanisms in high-risk Indigenous children
高危原住民儿童的防龋机制
- 批准号:1063970410639704
- 财政年份:2023
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
Toll-like receptor control of endocytic antigen cross-presentation
Toll 样受体控制内吞抗原交叉呈递
- 批准号:1073535410735354
- 财政年份:2023
- 资助金额:$ 41.2万$ 41.2万
- 项目类别:
F plus G RSV VLP Vaccine for Improved Safety and Efficacy
F plus G RSV VLP 疫苗可提高安全性和有效性
- 批准号:1038348610383486
- 财政年份:2022
- 资助金额:$ 41.2万$ 41.2万
- 项目类别: